Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology
Volume 24, Issue 7, Pages 435-440
http://dx.doi.org/10.1155/2010/872570
Original Article

Overexpression of Cyclooxygenase-2 in Noncancerous Liver Tissue Increases the Postoperative Recurrence of Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Related Cirrhosis

Yi-Fu He,1,2 Juan Jin,1 Wei Wei,1 Yan Chang,1 Bing Hu,2 Chu-Shu Ji,2 Wei-Dong Jia,3 Xiao-Qiu Wang,4 Ke Chen,4 and Jian Chen2

1Institute of Clinical Pharmacology, Anhui Medical University Key Laboratory of Anti-inflammatory and Immune Pharmacology of the Education Ministry of China, China
2Department of Medical Oncology, Anhui Provincial Hospital affiliated to Anhui Medical University, Hefei, China
3Department of General Surgery, Anhui Provincial Hospital affiliated to Anhui Medical University, Hefei, China
4Department of Pathology, Anhui Provincial Hospital affiliated to Anhui Medical University, Hefei, China

Received 27 May 2008; Accepted 19 January 2010

Copyright © 2010 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [10 citations]

The following is the list of published articles that have cited the current article.

  • Ren Zhi-jian, Li Xun, Zhou Wen-ce, Zhang Hui, Meng Wen-bo, He Wen-ting, He Jian-hong, Li Yu-min, Zhang Quan-bao, He Jian-hong, Li Yu-min, Zhang Quan-bao, Ren Zhi-jian, Li Xun, Zhou Wen-ce, Zhang Hui, Meng Wen-bo, and He Wen-ting, “Cyclooxygenase-2 promoter polymorphism-899G/C is associated with hepatitis B-related liver cancer in a Chinese population of Gansu province,” Chinese Medical Journal, vol. 124, no. 24, pp. 4193–4197, 2011. View at Publisher · View at Google Scholar
  • Yi-Fang Han, Jun Zhao, Li-Ye Ma, Jian-Hua Yin, Wen-Jun Chang, Hong-Wei Zhang, Guang-Wen Cao, Yi-Fang Han, Jun Zhao, Li-Ye Ma, Jian-Hua Yin, Wen-Jun Chang, Hong-Wei Zhang, and Guang-Wen Cao, “Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma,” World Journal Of Gastroenterology, vol. 17, no. 38, pp. 4258–4270, 2011. View at Publisher · View at Google Scholar
  • Takayuki Nakase, Masaki Ueno, Kazuhisa Uchiyama, Nariaki Matsuura, and Hiroki Yamaue, “Expression of Cyclooxygenase-2 and Transforming Growth Factor-Beta 1 in Patients with the Early Recurrence of Hepatocellular Carcinoma Following Hepatectomy,” Surgical Science, vol. 03, no. 06, pp. 322–331, 2012. View at Publisher · View at Google Scholar
  • Yi-Ling Lin, Yuan-Yen Chang, Deng-Jye Yang, Bor-Show Tzang, Yi-Chen Chen, Yi-Ling Lin, Yuan-Yen Chang, Deng-Jye Yang, Bor-Show Tzang, and Yi-Chen Chen, “Beneficial effects of noni (Morinda citrifolia L.) juice on livers of high-fat dietary hamsters,” Food Chemistry, vol. 140, no. 1-2, pp. 31–38, 2013. View at Publisher · View at Google Scholar
  • Ana Campillo, Estela Solanas, Maria J. Morandeira, Tomas Castiella, Sara Lorente, Francisco Agustin Garcia-Gil, Elena Piazuelo, Alba de Martino, Maria T. Serrano, Ana Campillo, Estela Solanas, Maria J. Morandeira, Tomas Castiella, Sara Lorente, Francisco Agustin Garcia-Gil, Elena Piazuelo, Alba de Martino, and Maria T. Serrano, “Angiogenesis and proliferation markers in adjacent cirrhotic tissue could predict hepatocellular carcinoma outcome after liver transplantation,” European Journal Of Gastroenterology & Hepatology, vol. 26, no. 8, pp. 871–879, 2014. View at Publisher · View at Google Scholar
  • Chao Ou, Hai-Ping Zheng, Jian-Jia Su, Ji Cao, Guo-Jian Li, Le-Qun Li, Chao Ou, Hai-Ping Zheng, Jian-Jia Su, Ji Cao, Guo-Jian Li, and Le-Qun Li, “Effect of Ginkgo biloba extract on the expressions of Cox-2 and GST-Pi in rats with hepatocellular carcinoma risk,” African Health Sciences, vol. 14, no. 1, pp. 37–48, 2014. View at Publisher · View at Google Scholar
  • Chaohui Zuo, Xiaoxin Qiu, Nianli Liu, Darong Yang, Man Xia, Jingshi Liu, Xiaohong Wang, Haizhen Zhu, Hailong Xie, Hanguo Dan, Qinglong Li, Qunfeng Wu, Michael Burns, Chen Liu, Chaohui Zuo, Xiaoxin Qiu, Nianli Liu, Darong Yang, Man Xia, Jingshi Liu, Xiaohong Wang, Haizhen Zhu, Hailong Xie, Hanguo Dan, Qinglong Li, Qunfeng Wu, Michael Burns, and Chen Liu, “Interferon-alpha and cyclooxygenase-2 inhibitor cooperatively mediates TRAIL-induced apoptosis in hepatocellular carcinoma,” Experimental Cell Research, vol. 333, no. 2, pp. 316–326, 2015. View at Publisher · View at Google Scholar
  • Yuko Takami, Susumu Eguchi, Masaki Tateishi, Tomoki Ryu, Kazuhiro Mikagi, Yoshiyuki Wada, and Hideki Saitsu, “A randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatment,” Hepatology International, 2016. View at Publisher · View at Google Scholar
  • Hye Kyung Chang, Eun Young Chang, Seonae Ryu, and Seok Joo Han, “Cyclooxygenase-2 Inhibitor Reduces Hepatic Stiffness in Pediatric Chronic Liver Disease Patients Following Kasai Portoenterostomy,” Yonsei Medical Journal, vol. 57, no. 4, pp. 893, 2016. View at Publisher · View at Google Scholar
  • Shengnan Cai, Yue-xiang Zhang, Ke Han, and Yi-qian Ding, “Expressions and clinical significance of COX-2, VEGF-C, and EFGR in endometrial carcinoma,” Archives of Gynecology and Obstetrics, 2017. View at Publisher · View at Google Scholar